| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Travers & Co Accounting & Tax | 2,100 | 1,680 | 420 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| Publicly traded securities | 131,625 | 109,963 | 21,662 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 25M Wells Fargo 3.75% 10-01-14 | 25,203 | 26,360 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 200 shs Abbott Labs | 9,854 | 13,100 |
| 150 shs AT&T Inc | 4,184 | 5,057 |
| 400 shs Avon | 5,730 | 5,744 |
| 100 shs Berkshire Hathaway Class B | 6,572 | 8,970 |
| 400 shs Colgate Palmolive | 4,749 | 41,816 |
| 200 shs Danaher | 5,919 | 11,180 |
| 100 shs Dominion Resources | 3,379 | 5,180 |
| 75 shs Exxon Mobil | 3,454 | 6,491 |
| 1400 shs First Niagara Finl Group | 10,005 | 11,102 |
| 200 shs Haemonetics Corp | 5,425 | 8,168 |
| 100 shs Johnson & Johnson | 5,877 | 7,010 |
| 100 shs Pepsico | 5,838 | 6,843 |
| 100 shs Teva Pharmaceutical | 5,863 | 3,734 |
| 800 shs Woodward Inc | 3,332 | 30,504 |
| 100 shs 3M | 7,713 | 9,285 |
| 2400 shs Vanguard ST Bd Index Fd | 25,680 | 25,512 |
| 2000 shs Vanguard GNMA Fund | 21,100 | 21,820 |
| 120 shs IShares 3 Yr UST Index | 10,108 | 10,130 |
| 180 shs IShares 3 Yr UST Index | 15,244 | 15,196 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| NYS Filing fee | 100 | 100 | ||
| Broker fees | 1,950 | 1,560 | 390 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Excise tax | 200 | |||
| Foreign tax | 27 | 27 |